My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 169

    1.

    Positron emission tomography in staging early lung cancer: a randomized trial.

    Maziak DE, Darling GE, Inculet RI, Gulenchyn KY, Driedger AA, Ung YC, Miller JD, Gu CS, Cline KJ, Evans WK, Levine MN.

    Ann Intern Med. 2009 Aug 18;151(4):221-8, W-48. Epub 2009 Jul 6.PMID: 19581636 [PubMed - indexed for MEDLINE]Related articles

    2.

    PET-FDG scan enhances but does not replace preoperative surgical staging in non-small cell lung carcinoma.

    Poncelet AJ, Lonneux M, Coche E, Weynand B, Noirhomme P; Groupe d'Oncologie Thoracique des Cliniques Saint-Luc.

    Eur J Cardiothorac Surg. 2001 Sep;20(3):468-74; discussion 474-5.PMID: 11509265 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    F-18 fluorodeoxyglucose positron emission tomography in the non-invasive staging of non-small cell lung cancer.

    Berlangieri SU, Scott AM, Knight SR, Fitt GJ, Hennessy OF, Tochon-Danguy HJ, Clarke CP, McKay WJ.

    Eur J Cardiothorac Surg. 1999 Sep;16 Suppl 1:S25-30.PMID: 10536941 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography.

    Lardinois D, Weder W, Hany TF, Kamel EM, Korom S, Seifert B, von Schulthess GK, Steinert HC.

    N Engl J Med. 2003 Jun 19;348(25):2500-7.PMID: 12815135 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Non-small cell lung cancer staging: efficacy comparison of integrated PET/CT versus 3.0-T whole-body MR imaging.

    Yi CA, Shin KM, Lee KS, Kim BT, Kim H, Kwon OJ, Choi JY, Chung MJ.

    Radiology. 2008 Aug;248(2):632-42. Epub 2008 Jun 13.PMID: 18552311 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Clinical impact of (18)F fluorodeoxyglucose positron emission tomography in patients with non-small-cell lung cancer: a prospective study.

    Kalff V, Hicks RJ, MacManus MP, Binns DS, McKenzie AF, Ware RE, Hogg A, Ball DL.

    J Clin Oncol. 2001 Jan 1;19(1):111-8.PMID: 11134203 [PubMed - indexed for MEDLINE]Related articles

    7.

    Preoperative staging of lung cancer with combined PET-CT.

    Fischer B, Lassen U, Mortensen J, Larsen S, Loft A, Bertelsen A, Ravn J, Clementsen P, Høgholm A, Larsen K, Rasmussen T, Keiding S, Dirksen A, Gerke O, Skov B, Steffensen I, Hansen H, Vilmann P, Jacobsen G, Backer V, Maltbaek N, Pedersen J, Madsen H, Nielsen H, Højgaard L.

    N Engl J Med. 2009 Jul 2;361(1):32-9.PMID: 19571281 [PubMed - indexed for MEDLINE]Related articles

    8.

    Fluorodeoxyglucose positron emission tomography integrated with computed tomography to determine resectability of primary lung cancer.

    Nakamura H, Taguchi M, Kitamura H, Nishikawa J.

    Gen Thorac Cardiovasc Surg. 2008 Aug;56(8):404-9. Epub 2008 Aug 13.PMID: 18696206 [PubMed - indexed for MEDLINE]Related articles

    9.

    The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high.

    Turkmen C, Sonmezoglu K, Toker A, Yilmazbayhan D, Dilege S, Halac M, Erelel M, Ece T, Mudun A.

    Clin Nucl Med. 2007 Aug;32(8):607-12.PMID: 17667432 [PubMed - indexed for MEDLINE]Related articles

    10.

    Bone and soft-tissue sarcoma: preoperative staging with fluorine 18 fluorodeoxyglucose PET/CT and conventional imaging.

    Tateishi U, Yamaguchi U, Seki K, Terauchi T, Arai Y, Kim EE.

    Radiology. 2007 Dec;245(3):839-47.PMID: 18024454 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Diagnosis efficacy of structural (CT) and functional (FDG-PET) imaging methods in the thoracic and extrathoracic staging of non-small cell lung cancer.

    Rodríguez Fernández A, Gómez Río M, Llamas Elvira JM, Sánchez-Palencia Ramos A, Bellón Guardia M, Ramos Font C, Torné Poyatos P, Pedraza Muriel V.

    Clin Transl Oncol. 2007 Jan;9(1):32-9.PMID: 17272228 [PubMed - indexed for MEDLINE]Related articles

    12.

    Non-small cell lung cancer: dual-modality PET/CT in preoperative staging.

    Antoch G, Stattaus J, Nemat AT, Marnitz S, Beyer T, Kuehl H, Bockisch A, Debatin JF, Freudenberg LS.

    Radiology. 2003 Nov;229(2):526-33. Epub 2003 Sep 25.PMID: 14512512 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Staging non-small cell lung cancer with whole-body PET.

    Marom EM, McAdams HP, Erasmus JJ, Goodman PC, Culhane DK, Coleman RE, Herndon JE, Patz EF Jr.

    Radiology. 1999 Sep;212(3):803-9.PMID: 10478250 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients.

    Vansteenkiste JF, Stroobants SG, De Leyn PR, Dupont PJ, Bogaert J, Maes A, Deneffe GJ, Nackaerts KL, Verschakelen JA, Lerut TE, Mortelmans LA, Demedts MG.

    J Clin Oncol. 1998 Jun;16(6):2142-9.PMID: 9626214 [PubMed - indexed for MEDLINE]Related articles

    15.

    Mediastinal lymph node staging with FDG-PET scan in patients with potentially operable non-small cell lung cancer: a prospective analysis of 50 cases. Leuven Lung Cancer Group.

    Vansteenkiste JF, Stroobants SG, De Leyn PR, Dupont PJ, Verschakelen JA, Nackaerts KL, Mortelmans LA.

    Chest. 1997 Dec;112(6):1480-6.PMID: 9404742 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Non-small cell lung cancer: whole-body MR examination for M-stage assessment--utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT.

    Ohno Y, Koyama H, Onishi Y, Takenaka D, Nogami M, Yoshikawa T, Matsumoto S, Kotani Y, Sugimura K.

    Radiology. 2008 Aug;248(2):643-54. Epub 2008 Jun 6.PMID: 18539889 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced nonsmall cell lung cancer--initial results.

    Plathow C, Aschoff P, Lichy MP, Eschmann S, Hehr T, Brink I, Claussen CD, Pfannenberg C, Schlemmer HP.

    Invest Radiol. 2008 May;43(5):290-7.PMID: 18424949 [PubMed - indexed for MEDLINE]Related articles

    18.

    Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis.

    Gould MK, Kuschner WG, Rydzak CE, Maclean CC, Demas AN, Shigemitsu H, Chan JK, Owens DK.

    Ann Intern Med. 2003 Dec 2;139(11):879-92. Review.PMID: 14644890 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    FDG-PET imaging for lymph node staging and pathologic tumor response after neoadjuvant treatment of non-small cell lung cancer.

    Ohtsuka T, Nomori H, Ebihara A, Watanabe K, Kaji M, Naruke T, Suemasu K, Uno K.

    Ann Thorac Cardiovasc Surg. 2006 Apr;12(2):89-94.PMID: 16702929 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Impact of [18F]FDG-PET on the primary staging of small-cell lung cancer.

    Brink I, Schumacher T, Mix M, Ruhland S, Stoelben E, Digel W, Henke M, Ghanem N, Moser E, Nitzsche EU.

    Eur J Nucl Med Mol Imaging. 2004 Dec;31(12):1614-20. Epub 2004 Jul 17.PMID: 15258700 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity